Skip to main content
Erschienen in: BMC Gastroenterology 1/2015

Open Access 01.12.2015 | Research article

A meta-analysis of the association between IL28B polymorphisms and infection susceptibility of hepatitis B virus in Asian population

verfasst von: Jing Chen, Wei Wang, Xiaoguang Li, Jie Xu

Erschienen in: BMC Gastroenterology | Ausgabe 1/2015

Abstract

Background

Several association studies with small sample sizes of two SNPs in IL28BB (rs12979860 and rs8099917) showed inconsistent results, so in this study, we aim to evaluate the association between the two SNPs and infection susceptibility of Hepatitis B Virus (HBV) in Asian population, especially in Chinese population by meta-analysis.

Methods

Search the relevant published papers and perform meta-analysis respectively on IL28B (rs12979860 and rs8099917) in Asian population and Chinese population under an additive genetic model by STATA11.0.

Results

The pooled odds ratios (OR) of rs12979860 are 0.79 (95% CI, 0.53-1.18; P = 0.25, I2 = 63.2%) and 1.62 (95% CI, 1.04-2.51; P = 0.033, I2 = 54.3%) respectively in Asian population and Chinese population analysis. The pooled OR of rs8099917 are 1.05 (95% CI, 0.93-1.19; P = 0.44, I2 = 43.3%) and 0.97 (95% CI, 0.84-1.23; P = 0.726, I2 = 15.6%) respectively in Asian population and Chinese population analysis.

Conclusion

Our study demonstrated that T allele of rs12979680 can increase the risk of HBV infection in Chinese population but not Asian population under an additive genetic model. There is no association between rs8099917 and HBV infection in Chinese population and Asian population.
Hinweise

Competing interests

The authors declare that they have no competing interests.

Authors’ contributions

CJ and XJ designed the study, CJ and LXG collected the papers and conducted statistical of the data. CJ and WW wrote the manuscript and performed the English editing. All the authors read and approved the final manuscript.
Abkürzungen
HBV
Hepatitis B virus
WHO
World Health Organization
IL28B
Interleukin 28B
GWAS
Genome-wide association studies
SNPs
Single nucleotide polymorphisms
HWE
Hardy-Weinberg equilibrium
OR
Odds ratios
CNKI
China National Knowledge infrastructure
SVR
Sustained virological response
ETR
End of treatment response
NVR
Null virological response
ALT
Glutamic-pyruvic transaminase

Background

Hepatitis B virus (HBV) is a worldwide health problem, and it is estimated that 2 billion individuals have been infected with HBV and 350 million are the chronic carriers. In the data of World Health Organization (WHO) in 1997, the rate of chronic HBsAg carriers in Asian is higher compared with other continents, HBsAg seroprevalence in the north and central Asian countries ranged between 10% and 12% and in Southeast Asia it ranged between 1% and 10% with a total number of 130 million. But in the United States and northern European countries, it is under 0.5% [1]. In the Chinese epidemiological investigation of HBV in 2006, the rate of chronic HBsAg carriers was 7.18%, and it is about 93 million patients with HBV chronic infection [2]. With the development of human genome research, there is strong evidence in HBV infection that host genetic factors play a major role in determining the outcome of infection. The incidence of hepatitis B in Asian is high, so there may be genetic susceptibility in Asian people. The researchers have done much study on this issue in recent years, and Interleukin 28B (IL28B) has been a hot research topic on hepatitis virus, especially hepatic C virus. IL28B plays an important role in the outcome of hepatic C virus by genome-wide association studies (GWAS) [3] and it could inhibit hepatitis B and C virus replication [4]. HBV and HCV share some similarities in pathogenesis, natural history and acquired immune responses, but the relationship between ILB28 and HBV is still unclear. Rs12979860 and rs8099917 were widely studied in the previous research, so in this study, we performed a meta-analysis on single nucleotide polymorphisms (SNPs) of IL28B (rs12979860 and rs8099917) to evaluate the relationships between the genetic loci and HBV in Asian population, especially in Chinese population.

Methods

Identification of eligible studies

We searched the databases including PubMed, MEDLINE, EMBASE, China National Knowledge infrastructure (CNKI) and WanFang database for case–control studies on IL28B published in Asian population up to March, 2015. The search terms included IL28B and Asian and HBV. Then we selected the papers included IL28B-rs12979860 and rs8099917 (Figure 1, Tables 1 and 2).
Table 1
Characteristics of the papers included in the meta-analysis and allele frequency of IL28B rs12979860 (C-T)
SNP
Area
Author
Year
allele frequency of HBV infection (N = 1,052)
allele frequency of control group (N = 2,823)
    
C
T
C
T
rs12979860
China
Shi et al. [16]
2011
153
11
34
0
 
China
Li et al. [10]
2011
760
104
382
24
 
China
Chen et al. [17]
2012
2238
172
455
33
 
China
Ren et al. [12]
2012
236
46
45
2
 
China
Lv et al. [18]
2012
488
36
525
29
 
Korea
Kim et al. [15]
2013
707
41
185
15
 
Thai
KimKong et al. [19]
2015
398
24
304
24
Sum
   
4,980
434
1,930
127
Table 2
Characteristics of the papers included in the meta-analysis and allele frequency of IL28B rs rs8099917 (T-G)
SNP
Area
Author
Year
allele frequency of HBV infection (N = 3,613)
allele frequency of control group (N = 1,409)
    
T
G
T
G
rs8099917
China
Li et al. [10]
2011
764
48
385
21
 
China
Chen et al. [17]
2012
2276
134
461
27
 
China
Ren et al. [12]
2012
248
34
45
2
 
Korea
Kim et al. [15]
2013
852
38
196
16
 
Thai
Kimkong et al. [19]
2015
402
20
303
25
 
China
Jiao et al. [11]
2011
643
41
276
12
 
China
Ma et al. [20]
2012
1494
90
947
67
Sum
   
6,679
405
2,989
170

The criteria of articles included and excluded in the meta-analysis

The articles included in the study should meet the following criteria: (1) the subjects were the Asian population; (2) the study was a case–control study including the HBV group and the control group. All patients with HBV infection were selected for the study including chronic hepatitis B patients, HBV-related HCC patients and inactive HBsAg carriers; (3) The articles included should be full text in Chinese or English, which supplied us with the sample size and the number of genotype and the frequency of the allele. (4) The papers should comply with the Hardy-Weinberg equilibrium (HWE) in health control group (5) Paper of the best quality was remained among the repeated published papers. (6) The papers should have been performed with the ethical approval and patient consent.
The criteria of articles excluded from the study were: (1) The papers of inappropriate statistically description or methods were removed; (2) Studies in which IL28B genotypes/alleles were not well defined (Figure 1).

Data extraction and analysis

We extracted data from the papers included (ethnicity, genotypic distribution and allelic frequency) and performed meta-analysis by STATA, version11.0 under an additive genetic model. (Tables 2 and 3) The heterogeneity was assessed by Cochran Q test (P <0.1 was considered to be significant). The heterogeneity was classed by I2 statistical test (I2 < 25%: low heterogeneity; I2 = 25–50%: moderate heterogeneity; I2 = 50–75%: high heterogeneity; I2 > 75%: extreme heterogeneity value) [5]. If P > 0.1 in Cochran Q test, the pooled ORs and 95% CIs were calculated in fixed effect model; otherwise in random effect model. Publication bias was evaluated by Begg’s test (P < 0.05 was considered to be significant).
Table 3
The result of meta-analysis of rs12979680 and rs8099917
SNPs
Ethnicity
Model
Pooled OR (95%CI)
P
Heterogeneity
Publication bias
     
I2
P
ɀ
P
rs12979680
Asian
Random
0.79 (0.53-1.18)
0.25
63.2%
<0. 1
0.30
0.76
rs12979680
Chinese
Random
1.62 (1.04-2.51)
0.033
54.3%
<0. 1
0.73
0.46
rs8099917
Asian
Fixed
1.05 (0.93-1.19)
0.44
43.3%
>0.1
0.9
0.37
rs8099917
Chinese
Fixed
0.90 (0.84-1.81)
0.726
15.6%
>0.1
1.71
0.09

Results

Results of meta-analysis of rs12979860 in Asian population

In the meta-analysis of rs12979860 in Asian population, the pooled sample included 2,823 subjects with HBV infection and 1,052 control subjects from 7 studies in Asian population. There was high heterogeneity among studies by Cochran Q test (P < 0.1, I2 = 63.2%) and a random effect model was performed under an additive model. The pooled OR of risk allele T was 0.79 (95% CI, 0.53-1.18; P = 0.25). No publication bias was found in the meta-analysis (corrected ɀ = 0.30 and corrected p = 0.76) (Figure 2A, Table 3).

Results of meta-analysis of rs12979860 in Chinese population

In the meta-analysis of rs12979860 in Chinese population, the pooled sample included 2,238 subjects with HBV infection and 788 control subjects from 5 studies in Chinese population. There was no heterogeneity among studies by Cochran Q test (P < 0.1, I2 = 54.3%) and a random effect model was performed under an additive model. The pooled OR of risk allele T was 1.62 (95% CI, 1.04-2.51; P = 0.033). No publication bias was found in the meta-analysis (corrected ɀ = 0.73 and corrected p = 0.46) (Figure 2B, Table 3).

Results of meta-analysis of rs8099917 in Asian population

In the meta-analysis of rs8099917, the pooled sample included 3,613 subjects with HBV infection and 1,409 control subjects from 7 studies in Asian population. There was no heterogeneity among studies by Cochran Q test (P > 0.1, I2 = 43.3%) and a fixed effect model was performed under an additive model. The pooled OR of risk allele T was 1.05 (95% CI, 0.93-1.19; P = 0.44). No publication bias was found in the meta-analysis (corrected ɀ =0.9 and corrected p = 0.37) (Figure 3A, Table 3).

Results of meta-analysis of rs8099917 in Chinese population

In the meta-analysis of rs8099917, the pooled sample included 3,048 subjects with HBV infection and 1,145 control subject from 5 studies in Chinese population. There was no heterogeneity among studies by Cochran Q test (P > 0.1, I2 = 15.6%) and a fixed effect model was performed under an additive model. The pooled OR of risk allele T was 0.97 (95% CI, 0.84-1.23; P = 0.726). No publication bias was found in the meta-analysis (corrected ɀ = 1.71 and corrected p = 0.09) (Figure 3B, Table 3).

Discussion

IL-28B belongs to the type III IFN family, and encodes a cytokine related to type I interferons and the IL-10 family. IL-28B, IL28A and IL29 are three closely related cytokine genes located on 19q13. Expression of the three genes can be induced by viral infection. Several GWAS studies on the SNP loci affecting antiviral therapy of HCV, and multiple SNPs on the IL28B gene were associated with sustained virological response (SVR). The link was strongest among rsl2979860 3 kb upstream of IL28B gene and rs8099917 8 kb upstream of the IL28B gene. Rsl2979860 is significantly associated with the response to Peg-IFN and ribavirin for patients with chronic HCV infection. In a study to investigate the association between rs12979860 and the end-of-treatment response (ETR) or SVR in the Chinese Han population, genotype CC was the main genotype (87.64%). The patients with genotype CC had higher rates of ETR and SVR than the patients with CT or TT genotype [6]. There are differences in response to treatment between patients of European ancestry and African-Americans. In patients of European ancestry, the CC genotype is associated with a twofold greater rate of SVR than the TT genotype, threefold in African- American and twofold in Hispanic population [7]. CC genotype of rsl2979860 strongly enhances resolution of HCV infection among individuals of both European and African ancestry [8]. The studies above suggest that the effect of rsl2979860 differs in races of diverse genetic background.
In Chinese patients with dual chronic infection with hepatitis B and C viruses, rs8099917 TG genotype could increase the risk of null virological response (NVR) (OR =2.37, P =0.017), and the GG genotype had a further increased risk of NVR (OR = 4.23, P = 0.027). The rs12979860 allele was associated with treatment failure (CT/TT vs. CC: OR =2.04, P =0.037). IL28B rs8099917 G variant leads to higher risk of NVR (P = 0.009) in HCV genotype 1 [8]. In GWAS to NVR in the treatment of patients with HCV genotype 1 of Japanese population, rs8099917 was strongly associated with NVR and SVR [9].
The relationship between IL28B and HCV is widely studied, but the association study between IL28B and HBV infection is much less and the results were inconsistent in previous studies. In two studies of rs12979680 on infection of hepatitis B virus in Chinese people, there was no association between rs12979680 and HBV infection [10,11]. In another Chinese study, both C allele and CC genotype were protective, which indicated that the rs12979860 TC polymorphism is associated with the carcinogenic process of chronic hepatitis B and HBV-related HCC [12]. In a meta-analysis of rs12979680, no significant correlation with HBV infection outcomes was found, and the pooled OR was 0.42 (95% CI, 0.11-1.51; P = 0.184, I2 = 75.9%) in Asian population [13]. But in our study, T allele of rs12979680 can increase the risk of HBV infection in Chinese population but not Asian population under an additive genetic model, the pooled OR (95% CIs) were 1.62 (1.04–2.51). Compared with the previous meta-analysis of rs12979680 (the included three papers was updated in July 2013) [14], our study contains more papers and more sample size. In the seven papers of our meta-analysis, there are five studies on Chinese population, one on Korea and one on Thai population, the frequency of T allele is 6.7 ~ 12.8% in Chinese population which is higher compared with 5.5% in Korea population and 6.4% in Thai population. The difference in the frequency of T allele in China, Korea and Thai may explain the inconsistent result in the meta-analysis on the Chinese population and the Asian population. However, the papers included in the meta-analysis are not enough and the result deserves more research to testify.
In our meta-analysis of rs8099917, there is no association between rs8099917 and susceptibility of HBV in both Chinese population and the Asian population. Jiao et al. demonstrate that rs8099917 is not associated with the HBV infection [11], which is consistent with our result. In another research, rs8099917 is strongly associated with glutamic-pyruvic transaminase (ALT) level and HBV viral load [10] IL28B rs8099917 AA genotype (AA vs AC + CC: odds ratio (OR) = 0.63) was associated with a decreased risk of HCC [13]. In a Korea study, rs8099917 is significantly associated with the outcomes of HBV infection [15]. The result deserves more research to testify.

Study limitations

There are several limitations that should be stated. First, the frequency of the allele is not classified by the hepatitis B virus genotypes which are different in different countries. Second, only seven papers were included in the meta-analysis, and so the association between IL28B (rs12979680 and rs8099917) and infection susceptibility of HBV in this meta-analysis deserves further replication.

Conclusions

In summary, our study demonstrated that T allele of rs12979680 can increase the risk of HBV infection in Chinese population but not Asian population under an additive genetic model. There is no association between rs8099917 HBV infection in Chinese population and Asian population.

Acknowledgements

We thank Dr. Jia Ying, Dr. Li Lu, Dr. Lin Fei, Dr. Liang Jingjin and other members of our department for their assistance in the study.
Open Access This article is licensed under a Creative Commons Attribution 4.0 International License, which permits use, sharing, adaptation, distribution and reproduction in any medium or format, as long as you give appropriate credit to the original author(s) and the source, provide a link to the Creative Commons licence, and indicate if changes were made.
The images or other third party material in this article are included in the article’s Creative Commons licence, unless indicated otherwise in a credit line to the material. If material is not included in the article’s Creative Commons licence and your intended use is not permitted by statutory regulation or exceeds the permitted use, you will need to obtain permission directly from the copyright holder.
The Creative Commons Public Domain Dedication waiver (https://​creativecommons.​org/​publicdomain/​zero/​1.​0/​) applies to the data made available in this article, unless otherwise stated in a credit line to the data.

Competing interests

The authors declare that they have no competing interests.

Authors’ contributions

CJ and XJ designed the study, CJ and LXG collected the papers and conducted statistical of the data. CJ and WW wrote the manuscript and performed the English editing. All the authors read and approved the final manuscript.
Literatur
1.
Zurück zum Zitat Custer B, Sullivan SD, Hazlet TK, Iloeje U, Veenstra DL, Kowdley KV. Global epidemiology of hepatitis B virus. J Clin Gastroenterol. 2004;38(10 Suppl 3):S158–68.CrossRefPubMed Custer B, Sullivan SD, Hazlet TK, Iloeje U, Veenstra DL, Kowdley KV. Global epidemiology of hepatitis B virus. J Clin Gastroenterol. 2004;38(10 Suppl 3):S158–68.CrossRefPubMed
2.
Zurück zum Zitat Chinese Society of Hepatology and Chinese Society of Infectious Diseases, Chinese Medical Association. The guideline of prevention and treatment for chronic hepatitis B (2010 version). Chin J Epidemiol. 2011;32(4):405–15. Chinese Society of Hepatology and Chinese Society of Infectious Diseases, Chinese Medical Association. The guideline of prevention and treatment for chronic hepatitis B (2010 version). Chin J Epidemiol. 2011;32(4):405–15.
3.
Zurück zum Zitat Tanaka Y, Nishida N, Sugiyama M, Kurosaki M, Matsuura K, Sakamoto N, et al. Genome-wide association of IL28B with response to pegylated interferon-alpha and ribavirin therapy for chronic hepatitis C. Nat Genet. 2009;41(10):1105–9.CrossRefPubMed Tanaka Y, Nishida N, Sugiyama M, Kurosaki M, Matsuura K, Sakamoto N, et al. Genome-wide association of IL28B with response to pegylated interferon-alpha and ribavirin therapy for chronic hepatitis C. Nat Genet. 2009;41(10):1105–9.CrossRefPubMed
5.
Zurück zum Zitat Higgins PT, Thompson GS. Quantifying heterogeneity in a meta-analysis. Stat Med. 2002;21:1539–58.CrossRefPubMed Higgins PT, Thompson GS. Quantifying heterogeneity in a meta-analysis. Stat Med. 2002;21:1539–58.CrossRefPubMed
6.
Zurück zum Zitat Liao XW, Ling Y, Li XH, Han Y, Zhang SY, Gu LL, et al. Association of genetic variation in IL28B with hepatitis C treatment-induced viral clearance in the Chinese Han population. Antivir Ther. 2011;16(2):141–7.CrossRefPubMed Liao XW, Ling Y, Li XH, Han Y, Zhang SY, Gu LL, et al. Association of genetic variation in IL28B with hepatitis C treatment-induced viral clearance in the Chinese Han population. Antivir Ther. 2011;16(2):141–7.CrossRefPubMed
7.
Zurück zum Zitat Ge D, Fellay J, Thompson AJ, Simon JS, Shianna KV, Urban TJ, et al. Genetic variation in IL28B predicts hepatitis C treatment-induced viral clearance. Nature. 2009;461(7262):399–401.CrossRefPubMed Ge D, Fellay J, Thompson AJ, Simon JS, Shianna KV, Urban TJ, et al. Genetic variation in IL28B predicts hepatitis C treatment-induced viral clearance. Nature. 2009;461(7262):399–401.CrossRefPubMed
8.
Zurück zum Zitat Thomas DL, Thio CL, Martin MP, Qi Y, Ge D, O’Huigin C, et al. Genetic variation in IL28B and spontaneous clearance of hepatitis C virus. Nature. 2009;461(7265):798–801.CrossRefPubMedPubMedCentral Thomas DL, Thio CL, Martin MP, Qi Y, Ge D, O’Huigin C, et al. Genetic variation in IL28B and spontaneous clearance of hepatitis C virus. Nature. 2009;461(7265):798–801.CrossRefPubMedPubMedCentral
9.
Zurück zum Zitat Guo X, Yang G, Yuan J, Ruan P, Zhang M, Chen X, et al. Genetic variation in interleukin 28B and response to antiviral therapy in patients withdual chronic infection with hepatitis B and C viruses. PLoS One. 2013;8(10):e77911.CrossRefPubMedPubMedCentral Guo X, Yang G, Yuan J, Ruan P, Zhang M, Chen X, et al. Genetic variation in interleukin 28B and response to antiviral therapy in patients withdual chronic infection with hepatitis B and C viruses. PLoS One. 2013;8(10):e77911.CrossRefPubMedPubMedCentral
10.
Zurück zum Zitat Li WY, Jiang YF, Jin QL, Shi LJ, Gao YH, Pan Y, et al. Expression and gene polymorphisms of interleukin 28B and hepatitis B virus infection in a Chinese Han population. Liver Int. 2011;31(8):1118–26.CrossRefPubMed Li WY, Jiang YF, Jin QL, Shi LJ, Gao YH, Pan Y, et al. Expression and gene polymorphisms of interleukin 28B and hepatitis B virus infection in a Chinese Han population. Liver Int. 2011;31(8):1118–26.CrossRefPubMed
11.
Zurück zum Zitat Jiao XL, Gao YT, Jing L, Liu T, Shi WX, Guo H, et al. Studies on the relationship between polymorphism of IL-28B rs8099917 and the outcome of HBV infection. Chin J Epidemiol. 2011;32(11):1143–7. Jiao XL, Gao YT, Jing L, Liu T, Shi WX, Guo H, et al. Studies on the relationship between polymorphism of IL-28B rs8099917 and the outcome of HBV infection. Chin J Epidemiol. 2011;32(11):1143–7.
12.
Zurück zum Zitat Ren SH, Lu JF, Du XF, Huang YX, Ma LN, Huo HL, et al. Genetic variation in IL28B is associated with the development of hepatitis B-related hepatocellular carcinoma. Cancer Immunol Immunother. 2012;61:1433–9.CrossRefPubMed Ren SH, Lu JF, Du XF, Huang YX, Ma LN, Huo HL, et al. Genetic variation in IL28B is associated with the development of hepatitis B-related hepatocellular carcinoma. Cancer Immunol Immunother. 2012;61:1433–9.CrossRefPubMed
13.
Zurück zum Zitat Xia P, Zhou M, Dong DS, Xing YN, Bai Y. Association of polymorphisms in interleukin-18 and interleukin-28B genes with outcomes of hepatitis B virus infections: a meta-analysis. Tumor Biol. 2014;35:1129–37.CrossRef Xia P, Zhou M, Dong DS, Xing YN, Bai Y. Association of polymorphisms in interleukin-18 and interleukin-28B genes with outcomes of hepatitis B virus infections: a meta-analysis. Tumor Biol. 2014;35:1129–37.CrossRef
14.
Zurück zum Zitat Tang SD, Yue M, Wang JJ, Zhang Y, Yu RB, Su J, et al. Associations of IFN-γ rs2430561 T/A, IL28B rs12979860 C/T and ERα rs2077647 T/C polymorphisms with outcomes of hepatitis B virus infection: a meta-analysis. J Biomed Res. 2014;28(6):484–93.PubMedPubMedCentral Tang SD, Yue M, Wang JJ, Zhang Y, Yu RB, Su J, et al. Associations of IFN-γ rs2430561 T/A, IL28B rs12979860 C/T and ERα rs2077647 T/C polymorphisms with outcomes of hepatitis B virus infection: a meta-analysis. J Biomed Res. 2014;28(6):484–93.PubMedPubMedCentral
15.
Zurück zum Zitat Kim SU, Song KJ, Chang YH, Shin EC, Park JY, Kim DY, et al. Association between IL28B polymorphisms and spontaneous clearance of hepatitis B virus infection. PLoS One. 2013;8(7):e69166.CrossRefPubMedPubMedCentral Kim SU, Song KJ, Chang YH, Shin EC, Park JY, Kim DY, et al. Association between IL28B polymorphisms and spontaneous clearance of hepatitis B virus infection. PLoS One. 2013;8(7):e69166.CrossRefPubMedPubMedCentral
16.
Zurück zum Zitat Shi XD. Genetic variation and expression of IL28B are associated with HCV and HBV infection in Chinese population. Jilin: Jilin University; 2011. Shi XD. Genetic variation and expression of IL28B are associated with HCV and HBV infection in Chinese population. Jilin: Jilin University; 2011.
17.
Zurück zum Zitat Chen J, Wang LL, Li Y, Cai B, Fu Y, Liao Y, et al. Association analysis between SNPs in IL-28B gene and the progress of hepatitis B infection in Han Chinese. PLoS One. 2012;7(12):e50787.CrossRefPubMedPubMedCentral Chen J, Wang LL, Li Y, Cai B, Fu Y, Liao Y, et al. Association analysis between SNPs in IL-28B gene and the progress of hepatitis B infection in Han Chinese. PLoS One. 2012;7(12):e50787.CrossRefPubMedPubMedCentral
18.
Zurück zum Zitat Lv JN. Study of the association of interleukin-28B gene polymorphism with prognosis of disease and response to antiviral treatment with PEG-IFN-2αin hepatitis C virus/hepatitis B virus infected patients. Jilin: Jilin University; 2013. Lv JN. Study of the association of interleukin-28B gene polymorphism with prognosis of disease and response to antiviral treatment with PEG-IFN-2αin hepatitis C virus/hepatitis B virus infected patients. Jilin: Jilin University; 2013.
19.
Zurück zum Zitat Kimkong I, Chankaew J, Kunanopparat A, Hirankarn N, Tangkijvanich P. Gene polymorphisms of interleukin 28B and the risk to chronic hepatitis B virus infection in Thai. Tissue Antigens. 2015;85(3):177–81.CrossRefPubMed Kimkong I, Chankaew J, Kunanopparat A, Hirankarn N, Tangkijvanich P. Gene polymorphisms of interleukin 28B and the risk to chronic hepatitis B virus infection in Thai. Tissue Antigens. 2015;85(3):177–81.CrossRefPubMed
20.
Zurück zum Zitat Ma N. Impact of candidate genetic polymorphisms on the infection and infection outcomes of hepatitis B virus. Hebei: Heibei Medical University; 2012. Ma N. Impact of candidate genetic polymorphisms on the infection and infection outcomes of hepatitis B virus. Hebei: Heibei Medical University; 2012.
Metadaten
Titel
A meta-analysis of the association between IL28B polymorphisms and infection susceptibility of hepatitis B virus in Asian population
verfasst von
Jing Chen
Wei Wang
Xiaoguang Li
Jie Xu
Publikationsdatum
01.12.2015
Verlag
BioMed Central
Erschienen in
BMC Gastroenterology / Ausgabe 1/2015
Elektronische ISSN: 1471-230X
DOI
https://doi.org/10.1186/s12876-015-0286-2

Weitere Artikel der Ausgabe 1/2015

BMC Gastroenterology 1/2015 Zur Ausgabe

Leitlinien kompakt für die Innere Medizin

Mit medbee Pocketcards sicher entscheiden.

Seit 2022 gehört die medbee GmbH zum Springer Medizin Verlag

Update Innere Medizin

Bestellen Sie unseren Fach-Newsletter und bleiben Sie gut informiert.